Literature DB >> 18797650

Tuberculosis control in vulnerable groups.

Jose I Figueroa-Munoz1, Pilar Ramon-Pardo.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18797650      PMCID： PMC2649499          DOI： 10.2471/blt.06.038737

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN： 0042-9686            Impact factor:   9.408


× No keyword cloud information.
  5 in total

1.  Pulmonary tuberculosis among political asylum seekers screened at Heathrow Airport, London, 1995-9.

Authors:  M E J Callister; J Barringer; S T Thanabalasingam; R Gair; R N Davidson
Journal:  Thorax       Date:  2002-02       Impact factor: 9.139

2.  A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users.

Authors:  R E Chaisson; G L Barnes; J Hackman; L Watkinson; L Kimbrough ; S Metha; S Cavalcante; R D Moore
Journal:  Am J Med       Date:  2001-06-01       Impact factor: 4.965

3.  Skin-test screening and tuberculosis transmission among the homeless.

Authors:  Po-Marn Kong; Jan Tapy; Patricia Calixto; William J Burman; Randall R Reves; Zhenhua Yang; M Donald Cave
Journal:  Emerg Infect Dis       Date:  2002-11       Impact factor: 6.883

4.  [Treatment of latent tuberculosis among homeless population. Comparison between wo therapeutic approaches].

Authors:  Ignacio Sánchez-Arcilla; José María Vílchez; Manuel García de la Torre; Xiomara Fernández; Arturo Noguerado
Journal:  Med Clin (Barc)       Date:  2004-01-24       Impact factor: 1.725

5.  Development of housing programs to aid in the treatment of tuberculosis in homeless individuals: a pilot study.

Authors:  P A LoBue; R Cass; D Lobo; K Moser; A Catanzaro
Journal:  Chest       Date:  1999-01       Impact factor: 9.410
  5 in total
  29 in total

1.  Prevalence and factors associated with tuberculosis treatment outcome among hazardous or harmful alcohol users in public primary health care in South Africa.

Authors:  K Peltzer; J S Louw
Journal:  Afr Health Sci       Date:  2014-03       Impact factor: 0.927

Review 2.  Prevalence of tuberculosis, hepatitis C virus, and HIV in homeless people: a systematic review and meta-analysis.

Authors:  Antonio Cassone
Journal:  Pathog Glob Health       Date:  2012-11       Impact factor: 2.894

Review 3.  Addressing the tuberculosis-depression syndemic to end the tuberculosis epidemic.

Authors:  A C Sweetland; A Kritski; M A Oquendo; M E Sublette; A Norcini Pala; L R Batista Silva; A Karpati; E C Silva; M O Moraes; J R Lapa E Silva; M L Wainberg
Journal:  Int J Tuberc Lung Dis       Date:  2017-08-01       Impact factor: 2.373

4.  Characteristics and treatment outcomes of tuberculosis cases by risk groups, Japan, 2007-2010.

Authors:  Kazuhiro Uchimura; Jintana Ngamvithayapong-Yanai; Lisa Kawatsu; Akihiro Ohkado; Takashi Yoshiyama; Akira Shimouchi; Kunihiko Ito; Nobukatsu Ishikawa
Journal:  Western Pac Surveill Response J       Date:  2013-03-31

Review 5.  Clinical mimics: an emergency medicine focused review of pneumonia mimics.

Authors:  Drew Alan Long; Brit Long; Alex Koyfman
Journal:  Intern Emerg Med       Date:  2018-03-26       Impact factor: 3.397

6.  Migrants and emerging public health issues in a globalized world: threats, risks and challenges, an evidence-based framework.

Authors:  Bd Gushulak; J Weekers; Dw Macpherson
Journal:  Emerg Health Threats J       Date:  2010-03-31

7.  Women, immigration, poverty and tuberculosis.

Authors:  Lucio Casali; Mariano E Crapa
Journal:  Multidiscip Respir Med       Date:  2010-12-20

8.  Peritoneal tuberculosis mimicking advanced ovarian carcinoma: an important differential diagnosis to consider.

Authors:  Maria A Gosein; Dylan Narinesingh; Gordon V Narayansingh; Nazreen A Bhim; Pearse A Sylvester
Journal:  BMC Res Notes       Date:  2013-03-09

9.  Spatial dependency of tuberculosis incidence in Taiwan.

Authors:  In-Chan Ng; Tzai-Hung Wen; Jann-Yuan Wang; Chi-Tai Fang
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

10.  Targeted screening and treatment for latent tuberculosis infection using QuantiFERON-TB Gold is cost-effective in Mexico.

Authors:  J L Burgos; J G Kahn; S A Strathdee; A Valencia-Mendoza; S Bautista-Arredondo; R Laniado-Laborin; R Castañeda; R Deiss; R S Garfein
Journal:  Int J Tuberc Lung Dis       Date:  2009-08       Impact factor: 3.427
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.